echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Blood System > JACC: Correlation between clonal hematopoiesis and the risk of heart failure progression with reduced left ventricular ejection fraction

    JACC: Correlation between clonal hematopoiesis and the risk of heart failure progression with reduced left ventricular ejection fraction

    • Last Update: 2021-04-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The accumulation of somatic DNA mutations is a sign of aging in many tissues.


    stem cell

    In population-based studies and patients with ischemic heart failure (HF) and reduced left ventricular ejection fraction (LVEF), clonal hematopoiesis driven by somatic mutations in hematopoietic cells is often referred to as uncertain potential clonal hematopoiesis (CHIP), and medsci.


    Uncertain potential of clonal hematopoietic (CHIP), and medsci.


    To evaluate the clinical impact of clonal hematopoiesis on the progression of heart failure of different etiologies

    The study cohort included 62 HF patients with LVEF<45% (74±7 years old, 74% male, 52% non-ischemic, LVEF 30±8%).


    62 HF patients with LVEF<45%

    CHIP mutations detected

    CHIP mutations detected

    Overall, 24 patients (38.


    CHIP mutations were detected in 24 patients (38.


    Correlation between CHIP mutations and hospital survival rate without HF

    Correlation between CHIP mutations and hospital survival rate without HF

    In single gene specific analysis, somatic mutations in DNMT3A or TET2 have a certain prognostic significance for HF-related death or hospitalization (DNMT3A mutation: HR 4.


    Somatic mutations in DNMT3A or TET2 have certain prognostic significance for HF-related death or hospitalization

    In summary, the somatic mutations driving clonal hematopoiesis are common in HF patients with reduced LVEF and are associated with accelerated progression of HF, regardless of the cause of HF.


    Somatic mutations that drive clonal hematopoiesis are common in HF patients with reduced LVEF and are associated with accelerated progression of HF

    Original source:

    Original source:

    Pascual-Figal Domingo A,Bayes-Genis Antoni,Díez-Díez Miriam et al.


    org/10.
    1016/j.
    jacc.
    2021.
    02.
    028" target="_blank" rel="noopener">Clonal Hematopoiesis and Risk of Progression of Heart Failure With Reduced Left Ventricular Ejection Fraction in this message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.